|
Journal of Clinical Psychopharmacology
The Journal of Clinical Psychopharmacology is a peer-reviewed medical journal published by Lippincott Williams & Wilkins covering clinical psychopharmacology. It was founded by Richard I. Shader, MD in 1981 as the first journal of an international scope devoted solely to clinical psychopharmacology.[1] David J. Greenblatt, MD served as Co-Editor-In-Chief. Drs. Shader and Greenblatt remained at the helm of the journal until both retired at the end of 2020.[2] Anthony J. Rothschild, MD[3] became JCP's new Editor-in-Chief in January 2021.[2] The first issue of the journal was published in January 1981.[4] It included articles on several psychopharmacological studies,[5][6] review articles,[7][8] a brief report of clinicians' observations,[9] an abstract,[10] a historical perspective article,[11] a book review,[12] a forensic update,[13] and a "Question the Experts" section.[14][15] According to the first editorial by the Editors-in-Chief, this format was chosen "to create a "one stop" journal in which clinicians and students could find a variety of avenues to learning."[1] The journal has since published bimonthly issues with a wide range of articles reporting on clinical trials and studies, side effects, drug interactions, overdose management, pharmacogenetics, pharmacokinetics, and psychiatric effects of non-psychiatric drugs.[16][17] Subscriptions to Journal of Clinical Psychopharmacology are managed through Lippincott Williams & Wilkins online store.[18] Abstracting and indexingAccording to the Journal Citation Reports, the journal's 2020 impact factor was 3.153.[19] In addition, the journal is abstracted and indexed in the Science Citation Index and PubMed/MEDLINE. See alsoReferences
External links
|
||||||||||||||||||||||||||||||||||||||
